(S)-Mephenytoin,
70989-04-7,
S-Mephenytoin,
Mephenytoin, D-,
(S)-(+)-Mephenytoin,
UNII-D9818430MW,
(5s)-5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione,
(S)-5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione,
(5S)-5-Ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione,
MFCD00270025,
D9818430MW,
NCGC00160394-01,
(S)-(+)-5-Ethyl-3-methyl-5-phenylhydantoin,
DSSTox_CID_26126,
DSSTox_RID_81360,
DSSTox_GSID_46126,
Mephenytoin, (+)-,
(S)-(+)-5-Ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione,
(+)-Mesantoin,
CAS-70989-04-7,
(+)-S-Mephenytoin,
(+)-Mephenytoin,
AC1Q6KZR,
AC1L32ZK,
SCHEMBL21768,
CHEMBL1743264,
DTXSID7046126,
BDBM21361,
CTK8E0472,
(S)-(+)-Mephenytoin, 98%,
GMHKMTDVRCWUDX-LBPRGKRZSA-N,
ZINC896648,
Tox21_111783,
AKOS030530599,
Tox21_111783_1,
NCGC00160394-02,
NCGC00165924-04,
(S)-5-Ethyl-3-methyl-5-phenylhydantoin,
FT-0605333,
Y1463,
A13366,
C20130,
(S)-(+)-Mephenytoin, solid, >=98% (HPLC),
UNII-R420KW629U component GMHKMTDVRCWUDX-LBPRGKRZSA-N,
2,4-Imidazolidinedione, 5-ethyl-3-methyl-5-phenyl-, (S)-,
d-Mephenytoin,
MEPHENYTOIN,
-MEPHENYTOIN,
C(Nc1ccc(Cl)cc1)c2ccc(C)cc2,
C12H14N2O2,
KST-1A7982,
AR-1A6510,
CID107921,
C12-H14-N2-O2,
73842-46-3,